In the present study, we show that genetic deletion of Fgf23 restricted to mature osteoblasts and osteocytes in mice with ARHR led to a partial correction of FGF23 levels, which was sufficient to fully correct hypophosphatemia. Here, FGF23 is linked to hypophosphatemia.